InsiderTrades

Form 4 for BDSX BIODESIX INC

Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0000905148-24-003059 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-13 2024-11-08 BDSX Vazquez Chris CAO M - OptEx — +602 11.8K +5% —
DM 2024-11-13 2024-11-11+ BDSX Vazquez Chris CAO S - Sale+OE $1.39 -203 11.7K -2% -$283.15
D 2024-11-13 2024-11-08 BDSX Vazquez Chris CAO M - OptEx $0.00 -602 3,008 -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-08 M A 602 — 11,790 D — — (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2 Common Common Stock 2024-11-12 S D 98 $1.40 11,587 D — — (F4) The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Common Common Stock 2024-11-11 S D 105 $1.39 11,685 D — — (F3) The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.36 to $1.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4 Derivative Restricted Stock Units 2024-11-08 M D 602 $0.00 3,008 D — · — to — 602 Common Stock (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F5) These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.